| NCT ID | NCT06932887 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | University of Utah |
| Condition | Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 346 participants |
| Start Date | 2025-05-28 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 346 participants in total. It began in 2025-05-28 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Beat Pain Better study examines strategies to increase the reach of evidence-based interventions for persons with osteoarthritis (OA) in communities that experience disparities. The study is a hybrid type 3 effectiveness-imple-mentation trial using sequential, multiple assignment, ran¬domi¬zation to evaluate 1) two text mes¬saging strat¬egies to reach persons with OA and enroll them in physical activity counseling provided by physical therapists; and 2) two strat¬egies to engage enrolled persons in the Walk with Ease (WWE) intervention for sustained self-management.
Eligibility Criteria
Inclusion Criteria: 1. Age 45 or older; 2. Visit in participating medical clinic within the past 6 months 3. OA diagnosis code related to lower extremity and/or spine on the problem list or associ¬ated with an encounter in the past 6 months 4. Has functioning cell phone able to receive calls and texts Exclusion Criteria: 1. Unable to participate in a regular walking program defined as the ability to walk for at least five minutes with or without the use of an assistive device. 2. Medical contraindication to participation in physical activity 3. Unable to communicate in either Spanish or English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06932887 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06932887 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 346 participants.
Is NCT06932887 currently recruiting?
Yes, NCT06932887 is actively recruiting participants. Contact the research team at julie.fritz@utah.edu for enrollment information.
Where is the NCT06932887 trial being conducted?
This trial is being conducted at Salt Lake City, United States, Salt Lake City, United States, West Valley City, United States.
Who is sponsoring the NCT06932887 clinical trial?
NCT06932887 is sponsored by University of Utah. The trial plans to enroll 346 participants.